Clinical Trials Logo

Poor Sleep Quality clinical trials

View clinical trials related to Poor Sleep Quality.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01602523 Active, not recruiting - Emphysema Clinical Trials

Effect of Symbicort on Sleep Quality in Patients With Emphysema

Start date: March 2011
Phase: Phase 3
Study type: Interventional

This study will look at the effects of the drug Symbicort on sleep quality. Symbicort is an inhaled medication that contains 2 drugs. One is a medication that opens up the airways (formoterol). The other is a steroid to decrease airway inflammation (budesonide). Symbicort is not an experimental medication. It is approved by the Food and Drug Administration for use in patients with emphysema. Patients with severe emphysema commonly sleep poorly. The cause of poor sleep in these patients is unknown. Symbicort may improve sleep quality by opening the airways and reducing lung inflammation. It is not known for sure if these effects actually improve sleep and quality of life. It is hoped that this study will answer this question.